CClinicalTrials.gg
Status unknownNCT00186719Updated Jul 26, 2011

How Smoking Causes COPD: Examination of Immune System Changes

An observational study in Chronic Obstructive Pulmonary Disease, sponsored by St. Joseph's Healthcare Hamilton. Status unknown at 1 site in Canada. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-07-26.

Sponsored by St. Joseph's Healthcare Hamilton · Observational

The sponsor has not verified this record recently (last verified Jul 2011), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
40 Years and older
Sex
All
01

Study summary

A breathing condition known as "chronic obstructive pulmonary disease" (COPD) caused by cigarette smoking is a major health problem. The way by which smoking leads to lung disease is uncertain. Recent research done in animals provides a description of specific changes (that is a reduction) in these immune cell types as a result of cigarette smoke exposure. The study you have been asked to participate in is a pilot study to see if similar changes occur in humans who smoke. The purpose of this study is to evaluate this new method of testing blood in 3 groups of 10 people: normal non-smoking subjects, subjects who smoke with no history of lung disease and subjects who smoke and have smoking related COPD.

Read the detailed description

The mechanism by which smoking leads to damage to lung tissue in susceptible hosts, is uncertain. Recently there has been description of specific changes (that is reduction) in the number and activity of certain key immune cell types - dendritic cells- as a result of cigarette smoke exposure. This work was done in animal models and we would like to develop methods that will allow us to examine if similar changes occur in humans who smoke. Reduced number and activity of dendritic cells would be expected to lead to increased incidence of infection - a common problem in patients with COPD.

Since dendritic cells come to the lung from the bloodstream, and one can detect them in the circulation, we will look at the dendritic cells that are present in the peripheral blood.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Smoking Related Disease
  • Immune System Changes
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's planned enrollment of 100 is below the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

St. Joseph's Healthcare Hamilton is the lead sponsor of 137 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

smokers and non-smokers

Inclusion criteria

  • Age > 40 years
  • Healthy Subjects - Non smokers
  • FEV1/FVC > 70% predicted
  • Current Smokers - > 10 pack year smoking history
  • FEV1/FVC > 70% predicted
  • Current Smokers with COPD - > 10 pack year smoking history
  • FEV1/FVC \< 70% predicted
  • Able to give informed consent

Exclusion criteria

Exclusion Criteria:

  • Healthy Subjects - Reside with smokers
  • History of lung disease
  • Current Smokers - History of lung disease
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
06

Study locations

1 of 1 sites recruiting
  • St Joseph's Healthcare
    Hamilton, Ontario L8N 4A6, Canada
    • Gerard Cox, MB FRCPC FRCPI · Contact · coxp@mcmaster.ca · 905-522-1155
    • Martin Stampfli, PhD · Contact · stampfli@mcmaster.ca · 905-525-9140
    • Gerard Cox, MB FRCPC FRCPI · Principal investigator
    • Martin Stampfli, PhD · Sub investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 26, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00186719
Lead sponsor
St. Joseph's Healthcare Hamilton
First posted
Sep 16, 2005
Start date
May 2005
Completion
Apr 2012 (estimated)
Last update
Jul 26, 2011

Study contacts

Susan E Carruthers, MLT
Contact
scarruth@stjosham.on.ca
905-522-1155 ext. 2208
Sarah E Goodwin, BA RRT CCRC
Contact
sgoodwin@stjosham.on.ca
905-522-1155 ext. 6130
Gerard Cox, MB FRCPC FRCPI
principal investigator · McMaster University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion